Biopharmaceutics 4.0, Advanced Pre-Clinical Development of mRNA-Encoded Monoclonal Antibodies to Immunosuppressed Murine Models

Administration of mRNA against SARS-CoV-2 has demonstrated sufficient efficacy, tolerability and clinical potential to disrupt the vaccination field. A multiple-arm, cohort randomized, mixed blind, placebo-controlled study was designed to investigate the in vivo expression of mRNA antibodies to immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouranidis, Andreas, Choli-Papadopoulou, Theodora, Papachristou, Eleni T., Papi, Rigini, Kostomitsopoulos, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402437/
https://www.ncbi.nlm.nih.gov/pubmed/34452015
http://dx.doi.org/10.3390/vaccines9080890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402437/
https://www.ncbi.nlm.nih.gov/pubmed/34452015
http://dx.doi.org/10.3390/vaccines9080890

Ejemplares similares